A single injection reversed Alzheimer’s symptoms in mice, and researchers say humans could be next
Alzheimer’s nanoparticle treatment developed by scientists in Spain and China reversed disease symptoms in mice with a single injection, according to a study published in Nature Nanotechnology. Rather than targeting amyloid-beta plaques directly, the engineered nanoparticles crossed the damaged blood-brain barrier and restored the brain’s own waste-clearance system. Within one hour, researchers recorded a sharp drop in toxic protein levels, with memory function fully restored and effects lasting the equivalent of decades in human terms. While mouse results don’t guarantee human outcomes, the mechanism targeting barrier function over individual markers may prove more durable than previous approaches.









